Loring Wolcott & Coolidge Fiduciary Advisors’s Verastem VSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.2K Hold
4,500
﹤0.01% 496
2026
Q1
$23.9K Hold
4,500
﹤0.01% 474
2025
Q4
$29.3K Sell
4,500
-1,449
-24% -$12.9K ﹤0.01% 452
2025
Q3
$46.5K Hold
5,949
﹤0.01% 431
2025
Q2
$24.7K Hold
5,949
﹤0.01% 440
2025
Q1
$42.4K Hold
5,949
﹤0.01% 389
2024
Q4
$33.9K Hold
5,949
﹤0.01% 431
2024
Q3
$19.6K Buy
5,949
+3,000
+102% +$8.14K ﹤0.01% 461
2024
Q2
$10.9K Hold
2,949
﹤0.01% 486
2024
Q1
$28.7K Hold
2,949
﹤0.01% 436
2023
Q4
$34.7K Hold
2,949
﹤0.01% 426
2023
Q3
$19K Hold
2,949
﹤0.01% 485
2023
Q2
$21.9K Hold
2,949
﹤0.01% 497
2023
Q1
$14.7K Hold
2,949
﹤0.01% 494
2022
Q4
$14.2K Buy
2,949
+1,500
+104% +$7.36K ﹤0.01% 485
2022
Q3
$15K Hold
1,449
﹤0.01% 506
2022
Q2
$20K Hold
1,449
﹤0.01% 506
2022
Q1
$25K Hold
1,449
﹤0.01% 507
2021
Q4
$36K Hold
1,449
﹤0.01% 490
2021
Q3
$54K Hold
1,449
﹤0.01% 455
2021
Q2
$71K Hold
1,449
﹤0.01% 441
2021
Q1
$43K Hold
1,449
﹤0.01% 298
2020
Q4
$37K Hold
1,449
﹤0.01% 453
2020
Q3
$21K Hold
1,449
﹤0.01% 465
2020
Q2
$30K Hold
1,449
﹤0.01% 418
2020
Q1
$46K Hold
1,449
﹤0.01% 386
2019
Q4
$23K Buy
1,449
+149
+11% +$2.14K ﹤0.01% 528
2019
Q3
$19K Hold
1,300
﹤0.01% 524
2019
Q2
$24K Buy
1,300
+1,050
+420% +$23.8K ﹤0.01% 495
2019
Q1
$9K Sell
250
-242
-49% -$9.56K ﹤0.01% 568
2018
Q4
$20K Buy
+492
New +$30K ﹤0.01% 523
2015
Q4
Sell
-288
Closed -$26K 676
2015
Q3
$26K Hold
288
﹤0.01% 478
2015
Q2
$26K Buy
+288
New +$30.5K ﹤0.01% 478

Other funds holding VSTM

Loring Wolcott & Coolidge Fiduciary Advisors's VSTM Position: Q2 2026 in Review

Loring Wolcott & Coolidge Fiduciary Advisors held its Verastem (VSTM) position steady in Q2 2026 at 4,500 shares worth $17.2K. The position accounts for ﹤0.01% of the portfolio, ranked #496.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in VSTM in Q2 2015 and has held it in 33 quarters since. The position peaked at $71K in Q2 2021. 72 funds tracked by Wall St. Rank hold VSTM as of Q2 2026.

  • Loring Wolcott & Coolidge Fiduciary Advisors held 4,500 shares of Verastem worth $17.2K as of Q2 2026.
  • Loring Wolcott & Coolidge Fiduciary Advisors left its Verastem share count unchanged in Q2 2026.
  • Verastem made up ﹤0.01% of Loring Wolcott & Coolidge Fiduciary Advisors's portfolio in Q2 2026, its #496 holding.
  • Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Verastem in Q2 2015 and has held it in 33 quarters since.
  • Loring Wolcott & Coolidge Fiduciary Advisors's Verastem position peaked at $71K in Q2 2021.
  • 72 funds tracked by Wall St. Rank held Verastem as of Q2 2026.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.